Approval · Notice of Compliance 4038 · 1997
PROPOFOL INJECTION: Notice of Compliance 4038
Issued November 27, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4038
- Date
- November 27, 1997
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anaesthetic sedative
- Canadian reference product
- DIPRIVAN (Zeneca Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL INJECTION | 02236887 | Cancelled Post Market |
Medicinal ingredients
- PROPOFOL 10 MG per ML